Cyprus participates in the global #MedSafetyWeek campaign

The Pharmaceutical Services of the Cyprus Ministry of Health announced the country's participation in the international #MedSafetyWeek campaign, which runs from November 2 to November 8, 2026. This global initiative aims to encourage patients and healthcare professionals to report any suspected side effects of medications, serving as a critical mechanism for monitoring drug safety and identifying potential health risks.

This year’s campaign is reported to be the largest to date, involving over 130 organizations from more than 120 countries, with awareness messages disseminated in over 60 languages. The central theme for the 2026 iteration is "Do not ignore suspected side effects – Report them," emphasizing the proactive role of the public in regulatory oversight.

Participants are urged to engage in various online and local awareness activities to help regulatory authorities take necessary safety measures. The Ministry of Health highlights that systematic reporting is essential for maintaining high safety standards across the pharmaceutical landscape. Interested parties are encouraged to utilize social media platforms to spread the message using the campaign's official hashtag to maximize global impact.